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Deletions of the azoospermia factor (AZF) regions of the Y chromosome are associated with severe
spermatogenic failure and represent the most frequent molecular genetic cause of azoospermia and
severe oligozoospermia. The exact role of the candidate AZF genes is largely unknown due to both the
extreme rarity of naturally occurring AZF gene-specific mutations and the lack of functional assays. Here,
we report the fine characterization of two different deletions in the USP9Y gene (one of the two candidate
genes in the AZFa region), which have been transmitted through natural conception in two unrelated families.
The associated mild testicular phenotype, in both cases, is in sharp contrast with that of the two previously
reported infertile patients bearing a mutation of the same gene. In conclusion, to date, the USP9Y gene has
been considered as one of the major Y-linked spermatogenesis genes, based on both its position within the
AZFa region and previous reports that correlated USP9Y mutation to severe spermatogenic failure and infer-
tility. This view is now substantially changed because our findings clearly demonstrate that during human
spermatogenesis, USP9Y is more likely a fine tuner that improves efficiency, rather than a provider of an
essential function. More importantly, the observed natural conceptions suggest that the protein is not
required for the final sperm maturation process or for the acquisition of sperm fertilizing ability, providing
a new perspective on the role played by the USP9Y gene in male fertility.
INTRODUCTION
The long arm of the human Y chromosome hosts a number of
genes involved in spermatogenesis and several types of recur-
rent Yq deletions are firmly associated with spermatogenic
failure (reviewed in 1–3 and references therein). However,
because each of these deletions removes multiple genes,
such observations do not allow attribution of spermatogenic
function to any particular Y chromosome encoded protein.
Despite the efforts of many laboratories, only two cases of
confirmed isolated Yq gene mutation have been reported to
date (4,5).
The rarity of single azoospermia factor (AZF) gene
mutations or deletions is in sharp contrast with the relatively
high frequency of AZF deletions [classically divided into
three AZF regions, AZFa, AZFb and AZFc (6)], which rep-
resent the most frequent molecular genetic cause of azoosper-
mia and severe oligozoospermia (,5 millions spermatozoa/
ml) (reviewed in 2 and references therein). A likely expla-
nation is that the peculiar structure and the sequence organiz-
ation of the Y chromosome make this chromosome prone to
the loss of large regions, such as the AZF regions.
AZFa deletion is relatively rare (less than 2% of Yq del-
etions observed in men tested because of low sperm count),
and in all known cases, it causes complete absence of germ
cells [Sertoli cell only syndrome (SCOS)] (7). AZFa region
contains two widely expressed genes, USP9Y and DDX3Y
(previously called DBY ) (3,8). USP9Y is the only Yq gene
for which isolated mutations have been reported: a massive
deletion removing entirety of USP9Y and a 4 bp splice-donor
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site deletion resulting in severely truncated protein (4,5). In
the first case, the outcome was severe oligospermia (3 millions
spermatozoa/ml), whereas the second case resulted in azoos-
permia. In both patients, testicular histology showed hyposper-
matogenesis with occasional tubules containing only
premeiotic or meiotic germ cells (spermatogenic arrest).
These findings lead to the conclusion that although complete
absence or significant truncation of USP9Y protein is not
enough to produce the full AZFa phenotype, it still causes
azoospermia or severe oligozoospermia and infertility. We
report two unique cases of deletions removing part of the
USP9Y gene which were spontaneously transmitted. In one
family, the transmission has occurred through two generations
and represents the first description of a familial case of partial
AZFa deletion. The second deletion was naturally transmitted
from a sub-fertile father to his son while the couple was on the
waiting list for assisted reproductive techniques. The observed
phenotypes provide important new insights into the role of
AZFa genes in male fertility.
RESULTS
Our attention was focused on two patients (1115/0 and A333)
of a large series of 995 subjects affected by infertility because
of the presence of deletions removing part of the USP9Y gene.
The frequency for isolated USP9Y gene-specific deletion in
this cohort is 0.2%, which confirms the rarity of these types
of deletions in the Y chromosome. In addition, 350 normo-
spermic men were screened for gene-specific deletions, with
no observed deletions for either of the two USP9Y markers.
Fine characterization of the deletions
In order to establish the exact extension and the mechanism of
formation of the deletions, we performed a fine mapping with
an additional set of markers, as reported in Tables 1 and 2.
Patient 1115/0 showed an intact Y chromosome following
the routine analysis, although gene-specific screening
showed the absence of exon 46 of USP9Y (with exon 22
present) (Fig.1). We used a number of additional gene-specific
markers (Table 1) to localize the breakpoints to intervals less
than 1 kb. After fine mapping of the deletion breakpoints, we
used long-range PCR to amplify and sequence the breakpoints
(Fig. 2A). The deletion removes 31925 bp with a proximal
breakpoint in USP9Y intron 33, whereas the distal breakpoint
is located 2366 bp downstream of the last USP9Y exon
(GenBank accession no. DQ665365).
Patient A333 showed a deletion of the AZFa markers which
are routinely used: sY86 and sY84. The gene-specific screen-
ing revealed the absence of exon 22 but the presence of exon
46 of USP9Y. We used a number of additional gene-specific
markers (Table 2) to localize the breakpoints to intervals
,1.5 kb. After fine mapping of the deletion breakpoints, we
used long-range PCR to amplify and then sequence the break-
points, as shown in Figure 2B. The deletion removes
389 404 bp with a proximal breakpoint 280 775 bp before
the first exon of USP9Y, whereas the distal breakpoint is
located in intron 28 of the USP9Y gene (GenBank accession
no. DQ665366).
The alignment of the flanking sequences (Fig. 2A and B)
shows that neither of these deletions is caused by ectopic
homologous recombination. This contrasts with the vast
majority of Y chromosomal deletions reported to date,
which appear to be caused by ectopic homologous recombina-
tion between direct repeats (3,9–12 and references therein).
Analysis of DNA from ejaculated spermatozoa
As it was not known whether the father of patient A333 had
the deletion, it was necessary to consider mosaicism as a poss-
ible explanation for the mild spermatogenic phenotype. In
order to rule out the presence of a mixed population of germ
cells with a proportion carrying an intact Y chromosome,
DNA was extracted from ejaculated spermatozoa of patient
A333. Sperm-derived DNA showed the same deletion
pattern as the genomic DNA (no amplification for sY84,
sY86 and exon 22 of USP9Y ) indicating that all spermatozoa
were derived from germ cells carrying the USP9Y deletion.
Gene expression analysis
As both patients presented spermatozoa in their ejaculate,
testis biopsy was not medically indicated and we were
unable to carry out testicular expression analysis.
Patient 1115/0. As the first 33 exons have been retained and
the distal breakpoint of the deletion falls between USP9Y,
which is partially deleted, and DDX3Y, which is retained,
we sought to verify the effect of the deletion on the expression
of both genes. RT–PCR revealed the presence of the 50 end of
USP9Y transcript and, as expected, the absence of its 30 end,
suggesting the translation of a truncated protein (Fig. 3A).
While performing the RT–PCR of the 50 end, we noticed
the presence of a strong band that migrated lower than
expected. The sequencing of this product showed a 60 bp del-
etion in the 50-UTR, where the first two non-transcribed exons
are located (Fig. 3C). These data indicate an alternative spli-
cing of the transcript, removing exon 2 from the gene
product (GenBank accession no. DQ151535). We found the
same alternatively spliced product in the mRNA originated
from the control testis and from two control men without Y
deletion (Fig. 3B). This alternatively spliced mRNA which
appears to be the major transcript in both leucocytes and
testes was not reported previously and its functional role is
yet to be established.
Because the position of the DDX3Y upstream regulatory
elements is unknown, we sought to verify DDX3Y transcrip-
tion, which may be affected by position effect silencing due
to the deletion. We ruled out this possibility after having per-
formed an RT–PCR analysis, which confirmed the presence of
both 50 and 30 DDX3Y transcripts in the patient’s lymphocytes
(Fig. 3A). In addition, in order to rule out a possible quantitat-
ive effect of the USP9Y deletion on DDX3Y expression, we
performed real-time PCR assay for DDX3Y. We did not
observe relevant differences in the expression of the
DDX3Y gene between patient 1115 and the two control men
(nomozoospermic/fertile without Y deletions) (data not
shown).
Patient A333. Although we were unable to carry expression
analysis in this patient, it is highly unlikely that the undeleted
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30 portion of USP9Y was transcribed, because the deletion
removed 28 kb of sequence upstream of the normal position
of the first exon.
Y chromosome analysis in male relatives
Our next step was to evaluate whether the deletion in patient
1115/0 occurred de novo. Patient’s father had died, but we
were able to obtain blood from two of his brothers and from
three of their male offspring. All male relatives lacked exon
46 of the USP9Y gene (Fig. 4A), and the same junction
sequence was successfully amplified with deletion-specific
primers (data not shown). The deletion therefore has been
transmitted from the father of the proband to three sons
without medical intervention. His age at the time of con-
ception of the first and last sons was 36 and 43, respectively.
The two brothers of the proband also induced spontaneous
pregnancies (one of them had two sons, the other had one
son), whereas the third cycle of in vitro fertilization was suc-
cessful for the 35-year-old proband 1115/0 (Fig. 4B). A
healthy baby girl was delivered a few months ago.
In order to verify the paternity and an eventual further
expansion of the deletion in patient A333, we analysed the
DNA of the son and found that the deletion was inherited
unchanged. In the same way, no further expansion of the del-
etion was observed in the sons of the brothers of proband
1115/0.
DISCUSSION
The AZFa region contains two genes, namely DDX3Y (former
DBY ) and USP9Y, and the removal of both genes is associated
with the complete absence of spermatogenic cells in the testis.
To date, only two infertile patients with confirmed deletions
inside or removing the whole USP9Y gene (4,5) have been
reported, and no cases of confirmed isolated DDX3Y deletions
have been published. A critical role only for DDX3Y [predomi-
nantly expressed in spermatogonia (13)] in the AZFa deletion
phenotype has been proposed on the basis of residual sperma-
togenesis in the testis of the two patients with USP9Y
mutation. However, a formal demonstration to support this
hypothesis is still lacking and the question about the exact
phase(s) of the spermatogenic process in which each of
these genes is participating needs to be clarified.
Our study provides new insights into the function of the
USP9Y gene. The natural transmission of deletions involving
the USP9Y gene suggests that the absence of the USP9Y
gene product does not preclude sperm-fertilizing ability and
thus it is not critical for the final sperm maturation process,
i.e. spermiogenesis. This observation radically changes our
view on the putative role of this protein, because the predicted
function of the USP9Y protein, as a deubiquitinating enzyme
involved in protein stability control, is expected to be relevant
in the late phases of spermatogenesis when active transcription
ceases (14). The recent observation of a likely non-functional
USP9Y gene product in the chimpanzee is intriguing, raising
questions about an essential role of this gene in primate’s sper-
matogenesis (15). However, the presence of moderate oli-
goasthenoteratozoospermia in both of our patients, and the
severe impairment of spermatogenesis in the two previously
reported cases, would predict a conserved (although probably
marginal) functional role for this gene in humans. The unaf-
fected expression level of the downstream DDX3Y gene
clearly demonstrate that the observed phenotypes are the
consequence of the USP9Y gene deletion.
Table 1. Primers for PCR amplification used for the fine mapping of the breakpoints in patient 1115/0
USTS Segment amplified Fragment length (bp) Primers (50!30)
Forward Reverse
1 Exon 22 204 ttttgtagcacaatttgcagg ttctgtggaatagggggatg
2 Exon 25 264 ggtgatggatgaggagtaaaaa cattcaagatcccagaactgtc
3 Exon 27 430 ggagtacctatcactgaatgtgc gtcattcatttctgcttggaac
4 Intron 33 401 gtattccctttgaagaaacatattg aagtccatcacaagttaatttttt
5 Intron 33 413 ttgcaagatgctattgctgg gccacctaccttcccttacc
6 Intron 33 370 catgcaaagaagcaggaaca attacaagcatgcaccacca
7 Intron 33 222 tcactggctgtgggacaac ccgtgcatctaacaccagaa
8 Intron 33 215 ggggtgtgtgtatgtgtgttg gcatggtcttgtgggaaaaa
9 Intron 33 218 gtgaacctcaacctgtgcct ttcccatgctatgccttttc
10 Intron 33 216 gcttgttcccagcaatttta cttgcagcatctttgtcagg
11 Intron 33 374 catggatgcaaaattccaca acagcggtggtataagtggg
12 Exon 34 472 aacggggaaacctttcactt taacaggttcaccccaaagc
13 Intron 34 292 tctctatggggtggttcctg gctgggattacagaagcctg
14 Exon 42 447 tgcacccatcaacttgacac ccatttgaccaactgatccc
15 Exon 46 111 gagcccatctttgtcagtttac ctgccaattttccacatcaacc
16 Post-USP9Y 260 attgcccatgcaaaagtagc tgcctgcttctgagactgaaa
17 Post-USP9Y 151 ttgtgttgagcacattccaaa aggcaggggaagagatgagt
18 Post-USP9Y 201 aactgcatcaagcccaaatc agtgtcgacattcctttcca
19 Post-USP9Y 209 gagaccagcatgggaaacat gcttctccaacctctctcca
20 Post-USP9Y 280 cttggaatcacagtgcatgg aaggaaaaggggccctaaat
21 Post-USP9Y 349 ttgcctaagataggggcctt caatatggtgagacccccac
22 Post-USP9Y 233 ggagacagaatgccaaggac gggggagggagaggtatatgt
23 Post-USP9Y 429 ttgatttgcatcccttaggc ttcggctcatgcttacaatg
aPrimer sequences used for junction amplification.
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DNA analysis of the male relatives was performed for only
one of the two previously reported carriers of USP9Y deletion/
mutation. In patient WHT2780, the de novo nature of the intra-
genic mutation has been confirmed (5). This patient was
affected by azoospermia, which by definition precludes spon-
taneous conception. It is clear that in both of our patients, and
in the 1115/0 patient’s relatives, the consequences of the
USP9Y loss are much less severe than in the previously
reported cases and are compatible with natural fertility. The
subfertility of patient 1115/0 is in contrast with the natural fer-
tility of his father and brother, but can be explained by the
well-known concept that fertility is not a synonym of normo-
zoospermia; therefore, the fertility of a couple depends on the
fertility status of both partners. The spontaneous pregnancies
achieved in couple A333 and in the father and brothers of
patient 1115/0 are typical examples for the potential compen-
sation of a highly fertile female partner for mild male factor.
How can the loss of the same gene (or part of it) be associ-
ated with such different spermatogenetic phenotypes in unre-
lated subjects? The deletion in the 1115 family leads to the
expression of a truncated protein, which might have preserved
some residual functional competence and it may explain the
milder phenotype. However, the structural analysis of the trun-
cated protein predicts a different scenario. The USP9Y gene
contains two highly conserved functional domains (Cys and
His domains, respectively), which are almost identical to
those found in mouse (Usp9x previously called Dffrx) and
on the human X chromosome (USPX ) homologues (4). The
deletion in the 1115 family has removed almost the entire pep-
tidase unit, including the His domain, whereas the Cys domain
remained intact. It is therefore unlikely that the truncated
protein has maintained a full biological function.
More importantly, a similar mild phenotype was found also
in patient A333 in which the USP9Y gene product is comple-
tely lacking due to the removal of the promoter region. This
observation clearly rules out a possible residual functional
competence as an explanation for the observed phenotypic
differences.
The widely heterogeneous phenotype can be related to the
different genetic background of the four individuals. For
example, the factor influencing the testis phenotype can be a
variation in the degree to which the X homologue USP9X
complements or compensates for absent or diminished
USP9Y function. It is also possible that the severe phenotype
in the two previously reported cases was related to the pre-
sence of other co-factors (including environmental or genetic
factors) or other pathological conditions affecting testis func-
tion. As the phenotypic description of these cases is focused
only on sperm analysis and the testicular histology, these
hypotheses cannot be ruled out.
The effect of the mutation on spermatogenesis may also
depend on other Y chromosome genes, and we have defined
the patient’s Y haplotype for future comparisons. Using six
biallelic markers (SRY1532, M9, 92R7, YAP, 12f2,
LLY22g), which are known to be polymorphic in the Euro-
pean populations (16), we assigned patient’s Y chromosome
Table 2. Primers for PCR amplification used for the fine mapping of the breakpoints in patient A333
STS Segment amplified Fragment length (bp) Primers (50!30)
Forward Reverse
P-1 Anonymus 494 tttggtctggggacacaagt caccgcagttctgcagc
P-2 Anonymus 587 tcttgaacagcatacgtggg tgcccacctcatcttccc
P-3 Anonymus 702 ccgccctccttttcattg tgaacttggttggcagagat
P-4 Anonymus 184 ccagatcaagttatttaggagagca tatgaatgggacgaggagg
P-5 Anonymus 250 gaggaggtatttcagggttctaag tctgtggttatcagtcagtgatca
P-6 Anonymus 374 gcaacactgaactggagcct ccacaagaaagatgctggct
P-7 Anonymus 168 ctgccattcctgccattca agcccaggagttcaaggtg
P-8 Anonymus 321 ggaaactggtgagaacccaaa cgaggatttatttccaccca
P-9 Anonymus 183 gcacttgcttggagtactgga actggagtgacgggggag
P-10 Anonymus 202 cctctcagctctacgtcccc aggtcagagagaggttgccc
P-11 Anonymus 256 aggcctcctccactgcat ggttcctgggtctctctcctt
P-12 Anonymus 226 aaacttgcacgcatgaatga cgcaaatgttgagtcactgg
P-13 Anonymus 411 gaaagagacgttggcccag tggcattcacctattcccac
P-14 Anonymus 443 aaattaaagaccggaacggc ataaaacgcatttggccatc
D-1 USP9Y intron 24 264 ggtgatggatgaggagtaaaaa cattcaagatcccagactgtc
D-2 USP9Y intron 26 430 ggagtacctatcactgaatgtgc gtcattcatttctgcttggaac
D-3 USP9Y intron 27 226 tgtattcgttttgtcgctgaa caaggaccagagtgttcaact
D-4 USP9Y intron 27 603 gatctggggtctgttctcca ttcccaggagtttgaggttg
D-5 USP9Y intron 27 268 cagtgcacaagtcctcctga caataggtgcagttggcaga
D-6 USP9Y intron 27 208 tattcctcccgtgttgaagc catggtggctcatgcctat
D-7 USP9Y intron 27 438 tgcctcagccttcagttttt attctcaatgtgaggccctg
D-8 USP9Y intron 27 334 acctttgacatgatccaccc gaactgctcctgtgccaact
D-9 USP9Y Exon 28 544 ccatactgggggtgagaagt accctaatccttttcagcca
D-10 USP9Y intron 28 363 gggaaaaatacactacgtcttgg accctaatccttttcagccaa
D-11 USP9Y intron 28 202 tggactctgagtgtagacttgtga accctaatccttttcagcca
D-12 USP9Y Exon 29 153 tgattatttcacacttttacggc accctaatccttttcagcca
D-13 USP9Y intron 29 117 aacctcctttcctcgtggtt ttcgacacctgtttcacctg
D-14 USP9Y intron 30 261 gcacccagcctctttaaggt tctcttaaagtgaggcacact
D-15 USP9Y intron 30 401 gtattccctttgaagaaacatattg aagtccatcacaagttaatttttt
aPrimer sequences used for junction amplification.
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to haplogroup Hgr2 (Y (xD,E,J,N,P) non-derived for patient
1115/0 and Hgr12 (hgr N) for patient A333. Unfortunately,
Y chromosome haplogroups of the previously described two
patients were not defined. Therefore, we could not compare
the Y backgrounds.
Apart from the moderate/mild oligoasthenoteratozoosper-
mia, the two patients and their relatives were healthy. This
is noteworthy because both USP9X and USP9Y are expressed
throughout the body. It is therefore likely that a double dosage
provided by the two homologous genes is required only for
germ cell development. It would be important, although diffi-
cult to perform, a genome-wide gene expression profiling in
these individuals in order to get further insights into the
effect of a reduced gene dosage in organs other than the testis.
Moreover, our finding raises questions about the appropri-
ateness of the currently used routine Y chromosome analysis
(17). On the basis of routine protocol, patient 1115/0 should
have been missed because the two routine markers (sY84
and sY86) mapping outside of the AZFa genes were present.
However, the rarity of isolated USP9Y deletions in our
study population and the absence of confirmed USP9Y-
specific deletions (apart from cases WHT2780 and Sayer) in
the literature make questionable its cost-effectiveness in a
routine diagnostic setting. However, the low frequency of
USP9Y gene-specific deletions may also be related to the
type of patients who are routinely tested for Y deletions, i.e.
severe oligospermic or azoospermic men. Nevertheless, the
analysis of the breakpoints of the intragenic deletion in the
1115 family did not reveal a potential hot spot for deletion for-
mation which makes unlikely the recurrence of this specific
event in other infertile men.
On the contrary, case A333 underlies the importance of the
definition of the extension of AZF deletions (‘partial’ or ‘com-
plete’) and thus the need for a second step analysis (18). For
this purpose, we would suggest performing a gene-specific
approach using the same or similar set of markers for the
two AZFa genes.
In conclusion, up to now the USP9Y gene was considered as
one of the major Y-linked spermatogenesis genes, both for its
position (AZFa region) and the previously reported genotype–
phenotype correlation (infertility due to severe spermatogenic
failure). This view is now substantially changed because our
findings clearly indicate that the protein is not required for
the acquisition of sperm-fertilizing ability. During human
spermatogenesis, its role is more likely a fine-tuner that
improves efficiency, rather than a provider of an essential
function.
MATERIALS AND METHODS
Subjects
After the routine analysis (discussed subsequently), 995 sub-
jects were identified without classical, or ‘complete’, AZF
deletions. The inclusion criteria of patients were based on
reduced or absent sperm counts and the lack of karyotype
anomalies. Eighty percent of patients were referred because
of a sperm concentration below 5 millions/ml, whereas the
remaining were in the mild or moderate oligospermic range
(5–20 millions spermatozoa/ml). Forty percent of patients
were defined as ‘idiopathic’ because of the absence of
known causes of spermatogenic disturbances. A total of 350
normospermic men were screened for AZF deletions and
USP9Y gene-specific deletions. Normospermia is character-
ized by the following sperm parameters: sperm concentration
.20 millions spermatozoa/ml; total sperm number/ejaculate
.40 millions spermatozoa; progressive sperm motility
Figure 1. Intragenic deletion of the USP9Y gene in patient 1115/0 and A333. PCR amplifications with the standard AZFa markers are shown on the right side of
the figure. Schematic representation of the Y chromosome, including the three AZF regions. STS markers used for the routine screening and the two AZFa genes
(USP9Y and DDX3Y ) with their exon/intron structure are shown and reported to scale. Coding exons in black. The extent of the deletions are shown as a gap
(shown to scale).
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Figure 2. Fine mapping of the deletion breakpoint. Additional markers with their GenBank position used to narrow down the deletion gap. (A) The final long-
range PCR product gave a band of about 800 bp in patient 1115/0, whereas no amplification was obtained in male and female controls. The chromatogram of the
sequence containing the breakpoints is shown. (B) the final long-range PCR product gave a band of about 1400 bp in patient A333, whereas no amplification was
obtained in male and female controls. The chromatogram of the sequence containing the breakpoints is shown. Alignment of the sequences flanking the break-
points is shown in the lower panel of each fine mapping scheme.
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type (a) . 25% or type (aþ b) . 50% and morphology
.30% (19).
We report the Y chromosome analysis and the subsequent
fine mapping of deletions in two unrelated subjects and in
their family members: (i) patient 1115/0, of Italian origin,
and his two brothers and three nephews and (ii) patient
A333, from Romania, and his son.
Probands
Patient 1115/0. A 34 years old man seeking genetic analysis
for infertility. The patient presented with moderate oligoasthe-
noteratozoospermia [sperm concentration 14 million sperma-
tozoa/ml; total progressive motility (type aþ b): 15%;
percentage normal forms: 20%] an uneventful medical
history and normal genitalia (bilateral testis volume: 15 ml).
The patient had a normal male karyotype (46,XY).
Patient A333. A 32 years old man seeking genetic analysis
for couple infertility with a history of a spontaneous abortion
(between the fouth and fifth week of pregnancy) 2 years
earlier. The patient underwent several sperm analyses and
presented a sperm count ranging from a minimum of
1.4 million spermatozoa/ml in September 2002 to 18 million
spermatozoa/ml in December 2003. The total progressive
motility (type aþ b) varied from 2 to 18%, whereas the per-
centage of normal forms varied from 1 to 4%. The patient
had an uneventful history and normal genitalia (bilateral
testis volume: 20 ml). Both partners had a normal karyotype
(46,XY and 46,XX).
Family of patient 1115/0
The patient’s father had died. His age at the time of conception
of three sons was 36, 37 and 43 years. We collected DNA
from all male family members. The two brothers 1115/1 and
1115/2 (39 and 40 years old, respectively, at the time of the
study) were able to spontaneously conceive children. Subject
1115/1 has two sons (1115/3 and 1115/4) conceived when
he was 36 and 38 years old, whereas subject 1115/2 has one
son (1115/5) conceived at the age of 37.
Figure 3. Expression analysis of the two AZFa genes performed in patient 1115/ (lymphocytes). (A) RT–PCR amplification using primers mapping into the 50
and 30 end of the two genes. No amplification of the 30 end of the USP9Y gene was observed, whereas the 50 end gave two bands. (B) RT–PCR amplification of
the 50 of the USP9Y gene in lymphocytes (C1) and in testis biopsy (C2) of a control non-deleted man. (C) Direct sequencing of the smaller RT–PCR (asterisk)
product confirmed that the untranslated exon 2 was not present.
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The son of patient A333
Patient A333 has naturally conceived (after 3 years from the
last pregnancy which ended with early abortion) a son who
was 9 months old when came under observation. The baby
presented normal male phenotype.
Informed consent to the molecular studies was obtained in
all family members.
Methods
Molecular analysis. Genomic DNA was extracted from leuco-
cytes using the standardized phenol–chloroform technique. In
patient A333, DNA was also extracted from ejaculated sper-
matozoa. Routine Y chromosome microdeletion screening
was performed according to the European Academy of
Andrology/EMQN Guidelines (17), which includes six STS
mapping into the three AZF regions and a pair of additional
gene-specific markers from the short arm of the Yp (SRY
and ZFX/ZFY). Patients presenting a deletion with the
routine panel were further analysed with specific markers in
order to define the type of deletion, i.e. complete or partial
(17,18). In patients presenting with an intact Y chromosome
from routine analysis, we performed a gene-specific
PCR-based screening including the following Yq genes:
USP9Y and DDX3Y (GenBank accession no. G49468) for
the AZFa region and HSFY (GenBank accession no. G6635)
and eIF-1AY (GenBank accession no. G29945) for the
AZFb region. Because USP9Y is composed of 46 exons dis-
tributed across 159 kb of genomic DNA, we use two primer
pairs, one mapping to exon 22 (GenBank accession no.
G54725) and another to exon 46 (GenBank accession no.
G34983).
We used a number of additional gene-specific markers
(Tables 1 and 2) to localize the breakpoints to intervals
,1 kb in patient 1115/0 and 1.5 kb in patient A333. The dele-
tion junction has been then amplified using long-range PCR,
and the amplified products were sequenced by automatic
sequencer (ABI PRISM 310, Applied Biosystems, Foster
City, CA, USA). The primers used for the long-range PCR
are indicated in the tables with (a).
Gene expression analysis in patient 1115/0. Total RNA has
been extracted from the patient’s lymphocytes using
TRIZOL reagent (Invitrogen Corporation, Carlsbad, CA,
USA) and from the control’s frozen testicular tissue using a
commercially available RNAeasy mini kit (Quiagen Inc.
Valencia, CA, USA). Testis tissue from man with normal sper-
matogenesis (obstructive azoospermia) was used as a control.
RNA integrity was assessed by electrophoresis in agarose gel.
For each sample, an amount of total RNA corresponding to
1 mg was reverse transcribed to cDNA in a final volume of
80 ml using TAqMan Reverse Trascription kit (Applied Bio-
systems) at the following conditions: 10 min at 258C, 30 min
at 488C and 5 min at 958C.
The sequences of the primer used for the detection of the 30
and 50 ends of the USP9Y and DDX3Y mRNA were the fol-
lowing:
USP9Y 50 for TGTTTTGCAGAGAGCTTGGA (exon 1)
USP9Y 50 rev GCTGTCGTTCCCTCCTACTG (exon 3)
USP9Y 30 for ATCCTCATTCACCTGCCTCT (exon 45)
USP9Y 30 rev ACTCCATGTTGGTTTGGAGC (exon 46)
DDX3Y 50 for ATTGGCAATCGTGAAAGACC (exon 5)
DDX3Y 50 rev TTACTGCCGGTTGCCTCTAC (exon 6)
DDX3Y 30 for GTTCCGGCTTTGGTGCTAGT (exon 16)
DDX3Y 30 rev GAGCTCCCTTGAATTATCAGGA (exon 17)
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